Hepeel

Quick links to important sections

Hepeel

Selected form

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hepeel

Quick Facts

Property Description
Active ingredient Multiple potentized substances (e.g., Lycopodium, Silybum, Phosphorus)
Form Oral tablets (sublingual/buccal)
Pharmacological class Combination Homeopathic Medicine
General Purpose Supportive care for liver and digestive function
Origin Heel, Germany (Bioregulatory Medicine)

What Type of Medicine is Hepeel?

Hepeel is a specific combination homeopathic medicine manufactured by the German company Heel, a recognized leader in Bioregulatory Medicine. This pharmacological class signifies that the product is prepared using highly diluted substances according to the monographs established for homeopathic products.

Hepeel is differentiated by its multi-component formulation, which combines several active ingredients intended to work synergistically. It is primarily available as an over-the-counter (OTC) oral tablet, designed to dissolve in the mouth, positioning it as a supportive, non-conventional remedy.


What Active Ingredients are in Hepeel?

Hepeel is a combination remedy that contains a precise blend of multiple potentized substances, primarily derived from plants—such as Lycopodium clavatum and Milk Thistle (Silybum marianum)—alongside the key mineral substance Phosphorus.

The inclusion of specific botanicals provides a connection to traditional pharmacological understanding. For instance, the active components in Milk Thistle are recognized for their antioxidant and hepatoprotective properties. This supports the ingredients’ potential relevance for aiding liver cell protection. The tablets are prepared using the excipient lactose monohydrate.


What is the General Purpose of Hepeel?

The general purpose of Hepeel is to provide supportive care for the liver and associated digestive functions by encouraging the body’s innate processes. Its traditional application focuses on helping to maintain the normal function of these crucial organs, which are central to the body's overall metabolic and eliminatory health.

The medicine's core mechanism principle involves offering a subtle stimulus to the biological system, aimed at bolstering functions like cellular protection. This approach aligns with supporting the body’s natural ability to maintain physiological balance and restoration.

Regulatory References

  1. European Medicines Agency (EMA)
  2. NIH Study on Silybum Marianum

What side effects are possible with Hepeel?

Possible Side Effects and Safety Information

The safety profile of Hepeel is primarily defined by the regulatory requirements for combination homeopathic medicines, focusing on officially documented adverse reactions and specific safety constraints.


Adverse Reaction Scope

Feature Regulatory Documentation Statement
Key adverse reaction categories Hypersensitivity reactions (allergic responses).
Frequency classification Adverse reactions involving hypersensitivity are officially classified as rare (affecting 1 to 10 users in 10,000).
System-organ classes involved Immune System Disorders and Skin and Subcutaneous Tissue Disorders (e.g., skin rash or itching).
Serious adverse reactions The potential for severe manifestations of hypersensitivity is the implied serious risk associated with the contraindication for known hypersensitivity to any component.

Safety Constraints and Considerations

Feature Regulatory Documentation Statement
Population-specific safety Use during pregnancy and lactation requires medical consultation. Due to the excipient lactose monohydrate, consultation is required for individuals with known lactose intolerance.
Exposure-related patterns A safety note exists regarding the possibility of a temporary worsening of existing symptoms (initial aggravation) upon treatment initiation.
Safety-related limitations The medicine is contraindicated in cases of known hypersensitivity to any of its components, including quinine (from Cinchona pubescens). Official documents also advise that liver diseases require medical diagnosis and supervision.

Regulatory Safety Summary

The official safety structure mandates the acknowledgment of rare allergic manifestations and specifies contraindications related to hypersensitivity. It further requires explicit notes regarding the lactose excipient and the specific regulatory recommendation for medical consultation during pregnancy and lactation. This framework structures the medicine's risk profile based on known components and regulatory classification, without offering clinical advice or interpretation.

Overdose and Emergency Response

Overdose and When to Seek Help

The information provided in this section is derived strictly from official government regulatory documents and prescribing information, without interpretation or clinical advice.

Officially Documented Overdose Profile

Regulatory Data Point Official Regulatory Status
Documented Manifestations None. Official labeling does not list specific clinical signs, symptoms, or lab abnormalities resulting from an acute overdose.
Specific Antidote None. No specific antidote is documented in official regulatory sources.
Supportive Measures Management consists of supportive treatment as deemed clinically necessary by a healthcare professional.

Required Emergency Action

Official regulatory information for this highly diluted homeopathic product does not contain specific overdose manifestations due to the nature of the preparation. Consequently, the primary instruction mandated by regulatory authorities focuses on the required actions for any adverse event.

Immediate medical attention must be sought for any new, unexpected, or serious adverse reaction experienced while using this medicine. A serious reaction is defined as any event that is life-threatening, requires hospital admission, or results in permanent disability.

Patients must contact a physician or emergency services immediately if a serious adverse event or life-threatening symptoms occur. No population-specific overdose considerations are documented in the available official product labeling.

Therapeutic Uses of Hepeel

Main Uses and Therapeutic Range

Hepeel is a homeopathic preparation traditionally utilized to support the functional health of the liver and gallbladder. It is primarily indicated for conditions involving non-inflammatory liver disorders and functional impairments of hepatic metabolism.

Common applications include:

  • Support for Primary Liver Dysfunction: Management of symptoms associated with minor liver disorders where the organ's metabolic or excretory functions require supportive care.
  • Gallbladder Support: Assistance in the management of functional biliary complaints, such as mild discomfort or congestion in the gallbladder region.
  • Symptomatic Relief of Digestive Distress: Addressing secondary symptoms of hepatic origin, including bloating, loss of appetite, and a sense of fullness.

Benefits and Physiological Support

The formulation is designed to act as a supportive therapy within a broader health management plan. Its primary benefits focus on the stabilization of biliary and hepatic processes without the use of aggressive chemical stimulants.

Functional Improvement

Hepeel is intended to stimulate the body's own regulatory mechanisms. By supporting the metabolic activities of the liver, it helps maintain the organ's role in detoxification and nutrient processing.

Holistic Integration

As a homeopathic medicinal product, it is often used to complement other therapeutic measures. Its non-directive action makes it suitable for individuals seeking supportive care for chronic functional issues where a gentle, regulatory approach is preferred.

Gastrointestinal Coordination

By addressing the root of hepatic and biliary sluggishness, the preparation helps in harmonizing the digestive process, potentially reducing the frequency of discomfort related to fat malabsorption or bile flow irregularities.

Regulatory References

  1. European Medicines Agency traditional use monograph on Milk Thistle

Eligibility and Restrictions for Use

The eligibility for using Hepeel is strictly defined by official regulatory documentation, primarily outlining patient groups and clinical conditions that constitute a contraindication or require conditional use.

Absolute Contraindications

Hepeel must not be used by the following groups:

  • Hypersensitivity: Individuals with a known allergy to any active substance, excipient, or component, specifically including quinine (a component of Cinchona pubescens).
  • Physiological Status: Women who are pregnant or breastfeeding (lactating) due to safety concerns associated with the Chelidonium majus content.

Conditional Use and Restrictions

Use of Hepeel requires special consideration or medical advice in certain populations:

  • Liver Disease: Patients with pre-existing liver diseases should only use this medicine under the supervision and explanation of a physician.
  • Biliary Conditions: Individuals with conditions such as gallbladder stones or jaundice must consult a doctor if complaints persist or if new ones arise.
  • Excipient Sensitivity: Patients with a known history of lactose intolerance should seek medical advice before use, as the tablets contain lactose monohydrate.

Age-Related Eligibility

No specific blanket age-based contraindication applies to the product, meaning eligibility for use in various age groups is governed by the absence of the above-listed contraindications and conditions requiring supervision.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes the official interaction profile for Hepeel, a combination homeopathic medicine, based strictly on authoritative government regulatory documentation.


Documented Interaction Profile

The regulatory profile is defined by the absence of specific, chemically documented drug-drug interactions. Across various national regulatory product summaries, the section dedicated to interactions explicitly states that “No interaction with other medicines is known.” Consequently, the label does not specify any contraindicated combinations, timing separation rules, or population-dependent interaction considerations related to co-administration with prescription or non-prescription drugs.


Interactions with Other Substances

While chemical drug interactions are not documented, the regulatory label for this class of medicine includes cautions regarding certain ingested non-medicinal substances.

Interacting Non-Medicinal Substances

Substance Category Official Statement in Regulatory Texts
Spicy foods, Mint Products, Exciting Substances May adversely affect the effectiveness of the homeopathic preparation.

This constraint is a general principle for this type of preparation, indicating that the medicine’s functional action may be hampered by these items, as reflected in official regulatory documentation.

Mechanism of Action

Cellular Antioxidant Defense Modulation

Hepeel's mechanism involves modulating key enzymes to influence the cell's capacity to neutralize damaging Reactive Oxygen Species (ROS), primarily by affecting the production of internal protective agents like glutathione ( GSH). This action is focused on modulating cellular redox pathways, which modifies the integrity of cell structures and membrane components.

Modulation of Apoptosis and Cell Viability Signaling

The drug's mechanism also addresses cell turnover by influencing the complex signaling pathways that control programmed cell death (apoptosis), particularly in stressed cells. By altering the balance of pro-survival and pro-death signals, this action affects the maintenance of viable cell populations and tissue architecture.

Influence on Biliary Motility and Excretory Pathways

A third component of the drug's mechanism is its influence on the biliary system, where it affects the motility of the bile ducts and the flow of bile. This targeted action on an excretory system modulates the function of the biliary system, affecting the movement of metabolic byproducts out of the affected area.

Dosage and Administration Information

The use of Hepeel is characterized by a specific route, dose, and frequency for the oral tablets. These parameters define a precise procedural structure for administration and consumption patterns.

Official Dosing and Frequency

Population Standard Dosing Frequency Acute Use Frequency (Max Daily)
Adults & Adolescents (12 years and older) One tablet, 3 times a day One tablet every 1/2 to 1 hour (Maximum 12 tablets)
Children (6–11 years) One tablet, 2 times a day One tablet every hour (Maximum 8 tablets)
Children (2–5 years) One tablet, 1–2 times a day One tablet every 1–2 hours (Maximum 6 tablets)

Administration Technique and Context

The approved route is oral, specifically requiring the tablet to be allowed to dissolve in the mouth (buccal/sublingual administration). For administration to younger children, the tablets may be crushed and mixed with a small amount of water.

Administration should be carried out outside of meals, meaning the tablet intake is separated from food consumption. The frequency of administration is typically reduced once an improvement in the patient’s condition is observed. The medicine is not intended for long-term continuous use without consultation, and prolonged use exceeding four weeks necessitates monitoring.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Hepeel

Evidence for Use in Functional Liver Disorders

Research has explored Hepeel in conditions characterized by functional imbalance, which often involve outcomes related to systemic or functional imbalance. Studies conducted in this area often include short-term, placebo-controlled trials, and some observational settings evaluating daily-life functioning. The populations studied typically consist of adults experiencing outcomes related to physical discomfort that may vary in intensity.

Studies report how symptoms evolved in the observed populations, and findings describe patterns observed during the study period. Specifically, some research describes patterns related to patient-reported outcomes describing perceived discomfort and outcomes reflecting daily functioning or activity level. Studies monitored patterns related to temporary physiological imbalance in some of the observed groups. However, evidence remains limited and heterogeneous across the small number of existing studies.

There is limited information for long-term outcomes, and certainty remains low regarding sustained changes. Follow-up durations were limited, meaning the stability of reported patterns beyond the study period is not fully established. Comparative evidence, which would allow assessment against other approaches, is also lacking.

Evidence from Preclinical and Laboratory Models

Research has explored how the preparation might interact with outcomes linked to inflammatory or irritative states and outcomes monitoring physiological strain or stress in non-human models, such as isolated cells or animal systems. This foundational research explored the preparation's interaction with outcomes linked to inflammatory or irritative states in cell and animal models.

Studies monitored the preparation's interaction in these simplified research settings. Research also explored outcomes related to physiological imbalance in these models. It is important to remember that these findings apply only to the specific conditions under which they were conducted.

What is Still Uncertain About the Research Evidence

The evidence base for Hepeel is characterized by several limitations. Sample sizes were modest in many studies, meaning findings describe group patterns, not personal outcomes, and may not generalize broadly. Furthermore, evidence quality varies across studies, and findings were mixed in some areas. There is limited information for long-term outcomes, and certainty remains low regarding the lasting impact of any observed changes. Comparative evidence that explores how Hepeel compares to other treatment or support approaches is also lacking.

Frequently Asked Questions (FAQ)

Common questions about Hepeel (FAQ)


Q: Do you need a prescription for Hepeel?

Official product registrations in many countries indicate that Hepeel tablets are often classified as a prescription-free or over-the-counter medicine. This means it is typically available for purchase without requiring a doctor’s prescription.


Q: Can Hepeel be used by people who are vegetarian or vegan?

The active ingredients in Hepeel are primarily plant- and mineral-derived. However, the tablets contain lactose monohydrate as an excipient. Individuals following strict dietary rules may wish to confirm the source and compliance of this excipient.


Q: Is it normal to feel a bit nauseous when first starting Hepeel?

Regulatory warnings mention the possibility of a temporary worsening of existing symptoms, which is sometimes called initial aggravation, upon starting the treatment. If this or any other unexpected effect persists, consultation with a healthcare professional may be appropriate.


Q: Does Hepeel interact with common painkillers like paracetamol (acetaminophen)?

According to the official product information, the regulatory profile states that 'No interaction with other medicines is known.' This statement is presented in official documents without further specification regarding specific drug names.


Q: Does Hepeel interact with blood thinners?

The official regulatory profile for Hepeel indicates that 'No interaction with other medicines is known.' Use for individuals taking blood thinners would fall under the broader consideration for consulting a healthcare provider before use.


Q: Can Hepeel be used during pregnancy or while breastfeeding (informational description only)?

Official regulatory documents state that use is contraindicated and the medicine is generally excluded from use during pregnancy or while breastfeeding. This is due to safety concerns associated with the inclusion of the ingredient Chelidonium majus.


Q: What if I experience an unexpected side effect from Hepeel?

Official instructions advise that if an initial worsening of symptoms persists or if any unexpected side effect is experienced, the use of the product should be stopped. Contacting a healthcare professional may be appropriate for reporting the reaction.


Q: Can Hepeel be used alongside prescribed medication?

Official regulatory text states 'No interaction with other medicines is known.' However, official information for individuals with existing conditions, particularly liver disease, notes that use is often conditional upon the supervision of a physician.


Q: Is Hepeel recognized by the FDA or a similar government body?

Hepeel is classified as a combination homeopathic medicine. As such, its regulation and recognition are subject to the specific framework and requirements that each national governing body applies to homeopathic products in its jurisdiction.


Q: Is Hepeel safe to take with common vitamins?

The regulatory profile states 'No interaction with other medicines is known,' and official information does not contain published warnings regarding interactions with common vitamins or dietary supplements.


Q: Are there any specific foods or drinks to avoid while using Hepeel?

Official warnings state that the medicine's effectiveness may be adversely affected by certain ingested substances. These include spicy foods, mint products, and exciting substances such as caffeine or strong herbal drinks.


Q: What are the most common reported side effects of Hepeel?

The official regulatory safety structure classifies hypersensitivity reactions (allergic responses) as rare (affecting 1 to 10 users in 10,000). Official documents do not provide frequency data for other non-allergic effects.


Q: Is Hepeel suitable for long-term use?

Official prescribing information indicates the medicine is not intended for long-term continuous use without consultation. If use continues beyond four weeks, official guidance notes that medical monitoring may be appropriate.


Q: Are there different forms of Hepeel available (e.g., tablet, liquid, injection)?

Product information indicates that different forms of Hepeel may be available across various markets. These typically include the oral tablets, ampoules (for injection), and sometimes oral drops (liquid).


Q: Is the evidence for Hepeel based on human or animal studies?

Research has included studies in both preclinical and laboratory models (such as cell systems or animal systems) and limited short-term studies in adult populations for functional liver disorders.


Q: How long does a typical course of Hepeel last?

The regulatory text does not define a standard course duration. It specifies that administration frequency must be reduced once an improvement in symptoms is observed, and use exceeding four weeks requires monitoring.


Q: Are there known issues with taking Hepeel on an empty stomach?

The official instruction is that administration of the tablet must be done outside of meals. This general guidance permits the use of the product during periods when the stomach is empty.


Q: Where is the official product information for Hepeel published?

The official prescribing information is published by the relevant national drug agency or intergovernmental body. This authority (such as the EMA/SmPC equivalent) is responsible for regulatory approval and documentation in a specific country.

How should Hepeel be stored and disposed of?

How to Store and Dispose of Hepeel?

Hepeel must be stored and discarded according to the official instructions provided in the medicine’s patient information. These instructions define the necessary conditions for product stability and public safety.

Storage Requirement Official Status
Temperature No special storage conditions are required (e.g., store at room temperature).
Protection Keep in the container and outer packaging to ensure product integrity and reference the expiry date.
Shelf-Life Do not use beyond the expiry date. It may be kept for 12 months after stopping use.

For safety, the official labeling mandates that this medicine must be kept out of the sight and reach of children.

Regarding disposal, medicines must not be thrown away via wastewater (e.g., flushed down the toilet) or household waste. Unused or expired product must be discarded by returning it to a pharmacist or local collection point.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hepeel found in:

A-Z Index: